Cybin announces results of annual and special meeting of shareholders and share consolidation

Toronto--(business wire)--cybin inc. (nyse american: cybn) (cboe ca:cybn) (cybin” or the “company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce the voting results for each of the matters presented at the company's annual and special meeting of shareholders held on august 27, 2024 (the “meeting”). there were 87 shareholders represented in person or.
CYBN Ratings Summary
CYBN Quant Ranking